Zimmer Biomet Holdings (LTS:0QQD) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QQD Zimmer Biomet Holdings Inc LTS:0QQD
68 GF Score
Price CHF77.38
GF Value CHF96.22
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0QQD vs STE, PEN, PODD: Short Interest Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zimmer Biomet Holdings Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Short Interest falls into.


LTS:0QQD
68GF Score
Zimmer Biomet Holdings Inc LTS:0QQD
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zimmer Biomet Holdings (LTS:0QQD) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF77.38 is trading 19.6% below its estimated GF Value™ of CHF96.22.

Key valuation signals for LTS:0QQD:

  • Short Interest:
  • GF Value™: CHF96.22 vs. price of CHF77.38 (19.6% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QQD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
68GF Score

Get the complete analysis for LTS:0QQD

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.38
Price
CHF96.22
GF Value